High expertise, high knowledge...
Technology & Products
Promethera Biosciences’ technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC). Promethera Biosciences has developed an innovative technology to isolate and expand the progenitor cell type in order to develop two products: HepaStem and H2Stem.
HepaStem is a therapeutic product designed to treat liver diseases by allogeneic liver injection of HHALPC.
Please click below to get access to a video describing The therapeutic road of HEPASTEM, a unique liver progenitor cell-based therapy.
PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01